Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.85 USD | +4.08% | +0.21% | -3.96% |
Business Summary
Number of employees: 267
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Stereopure Oligonucleotides
100.0
%
| 4 | 100.0 % | 113 | 100.0 % | +3,005.10% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Singapore, United States, Japan, United Kingdom, and Ireland
100.0
%
| 4 | 100.0 % | 113 | 100.0 % | +3,005.10% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul Bolno
CEO | Chief Executive Officer | 50 | 30/11/13 |
Kyle Moran
DFI | Director of Finance/CFO | 54 | 30/06/14 |
Chandra Vargeese
CTO | Chief Tech/Sci/R&D Officer | 63 | 31/07/14 |
Kate Rausch
IRC | Investor Relations Contact | - | - |
Corporate Officer/Principal | - | 31/01/22 | |
Corporate Officer/Principal | 46 | 31/03/14 | |
Linda K. Rockett
LAW | General Counsel | - | 31/01/16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Christian Henry
CHM | Chairman | 56 | 09/11/16 |
Mark Corrigan
BRD | Director/Board Member | 66 | 03/09/19 |
Adrian Rawcliffe
BRD | Director/Board Member | 52 | 31/01/17 |
Gregory Verdine
FOU | Founder | 65 | 22/07/12 |
Peter Kolchinsky
BRD | Director/Board Member | 47 | 31/12/14 |
Paul Bolno
CEO | Chief Executive Officer | 50 | 30/11/13 |
Heidi Wagner
BRD | Director/Board Member | 59 | 03/09/19 |
Ken Takanashi
BRD | Director/Board Member | 59 | 30/06/12 |
Aik Na Tan
BRD | Director/Board Member | 53 | 31/07/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 122,284,139 | 100,024,528 ( 81.80 %) | 0 | 81.80 % |
Stock B | 0 | 3,901,348 | 0 | 0 |
Company contact information
Wave Life Sciences Ltd.
Marina One East Tower 7 Straits View
018936, Singapore
+65 6236 3388
http://www.wavelifesciences.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.96% | 570M | |
-2.63% | 103B | |
+1.62% | 95.28B | |
+1.46% | 22.15B | |
-16.67% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
-13.21% | 16.05B | |
+5.41% | 13.68B | |
+33.57% | 12.17B |
- Stock Market
- Equities
- WVE Stock
- Company Wave Life Sciences Ltd.